Lv1
88 积分 2022-08-12 加入
Network Meta-Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease
1个月前
已完结
Comparative Efficacy and Safety of Endoscopic Modalities for Colorectal Cancer Screening in Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
1个月前
已完结
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial
1个月前
已完结
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial
2个月前
已完结
Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis
2个月前
已完结
Crohn's disease
4个月前
已完结
RISANKIZUMAB IMPROVES SYMPTOMS IN ADULTS WITH CROHN'S DISEASE IN CLINICAL PRACTICE: INITIAL RESULTS FROM THE ASPIRECD STUDY
5个月前
已关闭
MID-TERM OUTCOMES OF RISANKIZUMAB IN REFRACTORY CROHN'S DISEASE: A MULTICENTER REAL-WORLD STUDY IN ANDALUSIA, SPAIN
5个月前
已完结
REAL-WORLD EFFECTIVENESS OF RISANKIZUMAB IN ACHIEVING EARLY TRANSMURAL HEALING IN CROHN'S DISEASE: A PROSPECTIVE SINGLE-CENTER EXPERIENCE
5个月前
已关闭
皖公网安备34019202002308
